SciELO - Scientific Electronic Library Online

 
vol.71 número2Detección de alteraciones numéricas en el gen dys y su asociación con rasgos clínicosMielitis transversa relacionada con vacunación anti-influenza A(H1N1) índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Medicina (Buenos Aires)

versión impresa ISSN 0025-7680

Resumen

RODRIGUEZ-REIMUNDES, Ezequiel; PERAZZO, Florencia  y  VILCHES, Antonio R.. Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib. Medicina (B. Aires) [online]. 2011, vol.71, n.2, pp. 158-160. ISSN 0025-7680.

The tumor mor lysis syndrome (TLS) is a metabolic disorder resulting from a massive tumor breakdown. It is characterized by hyperuricemia, hyperphosphatemia, hypocalcemia and hyperkalemia and predisposes to acute renal failure. TLS usually occurs after the initiation of cytotoxic therapy and is more frequent in the case of neoplasias with a high proliferative rate or that are highly chemo-sensitive. We report the case of a man with a recurrent kidney cancer who presented with a TLS and acute renal failure after initiation of sunitinib.

Palabras clave : Tumor lysis syndrome; Sunitinib; Acute renal failure.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License